A lower ATP1A1/BCL2L1 ratio was a common feature of M6 AML patient blasts (Fig. 1A) and established cell lines (Supplementary Fig. S5G and Supplementary Table S10). Here, BCL2L1 is linked to acute myeloid leukemia.